Log In
Print this Print this

TK Sense

  Manage Alerts
Collapse Summary General Information
Company Panacea Pharmaceuticals Inc.
DescriptionRT-PCR test to predict patient response to imatinib
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsPredict response of chronic myelogenous leukemia patients to imatinib
Regulatory Designation
PartnerPanacea Global Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today